-
1. ImmunoGen, Inc. (IMGN) Stock Price, News, Quote & History - Yahoo Finance
Link: https://finance.yahoo.com/quote/IMGN
Description: WebA final decision is expected in August 2024. Find the latest ImmunoGen, Inc. (IMGN) stock quote, history, news and other vital information to help you with your stock trading and investing.
-
2. AbbVie to Acquire ImmunoGen, including its Flagship Cancer …
Link: https://news.abbvie.com/2023-11-30-AbbVie-to-Acquire-ImmunoGen,-including-its-Flagship-Cancer-Therapy-ELAHERE-R-mirvetuximab-soravtansine-gynx-,-Expanding-Solid-Tumor-Portfolio
Description: WebNov 30, 2023 · NORTH CHICAGO, Ill., and WALTHAM, Mass., Nov. 30, 2023 /PRNewswire/ -- AbbVie Inc. (NYSE: ABBV) and ImmunoGen, Inc. (NASDAQ: IMGN) today announced a definitive agreement under which AbbVie will acquire ImmunoGen, and its flagship cancer therapy ELAHERE ® (mirvetuximab soravtansine-gynx), a first-in-class antibody-drug …
-
3. IMGN Stock Price | Immunogen Inc. Stock Quote (U.S.: Nasdaq
Link: https://www.marketwatch.com/investing/stock/imgn
Description: WebFeb 9, 2024 · 0.16%. $207.4B. Amgen Inc. -1.27%. $155.8B. IMGN | Complete Immunogen Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full …
-
4. IMGN Stock: AbbVie To Buy ImmunoGen In $10.1 Billion Cash …
Link: https://www.investors.com/news/technology/imgn-stock-abbv-stock-biotech-acquisition-elahere/
Description: WebREINHARDT KRAUSE. 04:22 PM ET 11/30/2023. AbbVie ( ABBV) has agreed to buy ImmunoGen ( IMGN) for $10.1 billion in cash, offering a rich premium for the maker of ovarian cancer treatment drug...
-
5. AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $10.1 Billion
Link: https://finance.yahoo.com/news/abbvie-abbv-acquire-immunogen-imgn-105500834.html
Description: WebDecember 1, 2023 · 3 min read. AbbVie ABBV has announced a definitive agreement to acquire cancer biotech ImmunoGen IMGN for $10.1 billion, including its new ovarian cancer drug, Elahere.
-
6. ImmunoGen, Inc. Common Stock (IMGN) - Nasdaq
Link: https://www.nasdaq.com/market-activity/stocks/imgn
Description: WebDec 19, 2023 · IMGN. Edit my quotes. ImmunoGen, Inc. Common Stock (IMGN) Nasdaq Listed. 1. High Technical Attribute. Add to Watchlist. Add to Portfolio. Quotes. Dec 19, 2023. 7:00 am 10:00 am 11:00 am 12:00...
-
7. ImmunoGen, Inc. (IMGN) Company Profile & Facts - Yahoo Finance
Link: https://finance.yahoo.com/quote/IMGN/profile
Description: WebImmunoGen, Inc. (IMGN) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 31.23 0.00 (0.00%) At close: 04:00PM EST. Summary. Company Insights.
-
8. ImmunoGen, Inc. (IMGN) Stock Price, Quote, News & Analysis
Link: https://seekingalpha.com/symbol/IMGN
Description: WebFeb 12, 2024 · ImmunoGen, Inc. (IMGN) Stock Price, Quote, News & Analysis. Valuation. Charting. All. Analysis. Comments. News. Transcripts. SEC Filings. Press Releases. Related Analysis. IMGN Stock Price. 1D....
-
9. Investors | ImmunoGen, Inc.
Link: https://investor.immunogen.com/
Description: WebNov 2, 2023 · ImmunoGen, Inc. 830 Winter Street. Waltham, MA 02451-1477. Phone: (781) 895-0600. Email: [email protected]. Corporate Counsel.
-
10. Press Releases | ImmunoGen, Inc.
Link: https://investor.immunogen.com/press-releases
Description: WebDec 10, 2023 · WALTHAM, Mass. --(BUSINESS WIRE)--Jan. 3, 2024-- ImmunoGen, Inc. , (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the compensation committee of the Company’s Board of Directors (the “Compensation Committee”)